KREBS BIOCHEMICALS & INDUSTRIES Share Price

KREBS BIOCHEMICALS & INDUSTRIES Share Price

NSE: KREBSBIO
|
Pharmaceuticals
|
S Cap
₹ 55.21
-₹0.74 (-1.32%)
1D
Last updated 07 Sep, 2026, 15:21 IST

KREBS BIOCHEMICALS & INDUSTRIES Share Price Today

As of 7 Sep 2026, KREBS BIOCHEMICALS & INDUSTRIES share price is ₹55.21. The stock opened at ₹55.14, compared to its previous close of ₹55.95. During today's trading session, KREBS BIOCHEMICALS & INDUSTRIES share price moved in the range of ₹54.26 to ₹57.72, with an average price of ₹55.99 for the day. Looking at its last 52-week, the stock has touched a low of ₹38.33 and a high of ₹82.49. On the performance front, KREBS BIOCHEMICALS & INDUSTRIES share price has increased by 6.55% over the last six months and is down 21.45% on a year-on-year basis.

₹54.26
1.32% down today
₹57.72
1D LOW
1D HIGH

KREBS BIOCHEMICALS & INDUSTRIES Returns Calculator

Circuit
L
H
₹44.76
₹67.14
52-week
L
H
₹38.33
₹82.49

About KREBS BIOCHEMICALS & INDUSTRIES

KREBS BIOCHEMICALS & INDUSTRIES Share Price
ISIN
INE268B01013
Sector Market Cap
₹ 120.74 Cr

Krebs Biochemicals & Industries Ltd is an India-based company, which is engaged in the business of manufacture of active pharmaceutical ingredients. The Company manufactures bulk active pharmaceutical ingredients, pharmaceutical intermediates, fine chemicals, nutraceuticals utilizing two revenue streams: contract manufacturing for large pharmaceutical and multinational companies, and development of its products for sale in global markets. Its products include Androstenedione, Lovastatin, and Simvastatin. The Company’s pilot or research and development stages products are Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan, and Phenylephrine. The Company has two manufacturing facilities one at Regadichelaka, Nellore District and another one at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.

KREBS BIOCHEMICALS & INDUSTRIES Financial Highlights

  • Revenue: KREBS BIOCHEMICALS & INDUSTRIES reported revenue of ₹25.76 crore in FY26 vs ₹44.02 crore in FY25. It showed a decrease of 41.48% on a yearly basis.
  • Operating Profit: KREBS BIOCHEMICALS & INDUSTRIES reported an operating loss of ₹16.93 crore in FY26 vs ₹26.92 crore in FY25. It showed an increase of 37.11% on a year-on-year basis.
  • Net Profit: KREBS BIOCHEMICALS & INDUSTRIES reported a net loss of ₹16.93 crore in FY26 vs ₹26.94 crore in FY25. It showed an increase of 37.16% on a yearly basis.

KREBS BIOCHEMICALS & INDUSTRIES Quarterly Result Highlights

  • KREBS BIOCHEMICALS & INDUSTRIES reported revenue of ₹7.14 crore in Jun 2026, compared with ₹8.81 crore in Mar 2026, representing a decrease of 18.96% on a quarter-on-quarter (QoQ) basis.
  • KREBS BIOCHEMICALS & INDUSTRIES reported an operating loss of ₹2.48 crore in Jun 2026, compared with ₹2.34 crore in Mar 2026, representing a decrease of 5.98% on a quarter-on-quarter (QoQ) basis.
  • KREBS BIOCHEMICALS & INDUSTRIES reported a loss of ₹2.48 crore in Jun 2026, compared with ₹2.34 crore in Mar 2026, reflecting a decrease of 5.98% on a QoQ basis.
  • The earnings per share (EPS) of KREBS BIOCHEMICALS & INDUSTRIES stood at ₹12.49 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
72.74%
FII
0.50%
Other DII
0.00%
Retail and other
26.76%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.50%
Dec 20250.49%
Mar 20260.50%
Jun 20260.50%
Mkt Cap Cr
120.74
P/E
-8.56
P/B
0.00
ROE
10.40%
D/E
-1.38
ROCE
-9.06%
Div. Yield
0.00%
EPS(TTM)
-7.85
Turnover
0.15
EV/EBITDA
-933.35
Net Margin
0.00%
Op. Margin
0.00%
ROA
-8.63%
Quick Ratio
0.00
Curr. Ratio
0.19
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Krebs Biochem outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Krebs Biochem appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,55,634.0037.605.4513.74%0.6117.33%93.240.84%0.4810.90
Divis Laboratories2,41,576.0082.5914.4115.32%0.0019.56%629.490.33%0.5598.19
Torrent Pharmaceuticals1,84,478.0085.5721.9425.49%1.6913.85%222.760.70%0.4958.70
Cipla1,11,888.0033.343.2511.27%0.0014.95%423.360.94%0.4543.52
Zydus Lifesciences1,11,820.0024.354.1218.59%0.3117.35%237.300.09%0.3335.38
Laurus Labs99,417.5091.1818.7616.77%0.4016.14%97.200.11%0.6713.72
Lupin96,528.8017.394.3023.76%0.0424.88%659.000.85%0.57129.18
Dr. Reddy's Laboratories96,322.1030.262.5311.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma96,179.6046.525.9011.74%0.3413.13%396.980.04%0.4449.37
Aurobindo Pharma95,127.2025.642.519.25%0.1911.76%394.820.24%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

KREBS BIOCHEMICALS & INDUSTRIES Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹43.31₹50.42₹52.13₹59.70
Other Income₹0.71₹0.45₹0.62₹1.16
Total Revenue₹44.02₹50.87₹52.75₹60.86
Total Expenses₹70.94₹70.60₹77.45₹105.39
Profit Before Tax-₹26.92-₹19.73-₹24.69-₹44.53
Tax₹0.02₹0.00₹0.00₹0.00
Profit After Tax-₹26.94-₹19.73-₹24.69-₹44.53
EPS - Basic-₹12.49-₹9.15-₹11.30-₹20.81
EPS - Diluted-₹12.49-₹9.15-₹11.30-₹20.81

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹26.92-₹19.73-₹24.69-₹44.53
Income before WC changes-₹14.51-₹7.84-₹14.87-₹33.12
Change in Assets₹5.98-₹2.58₹19.12-₹13.97
Change in Liabilities₹0.66₹12.79-₹28.96₹29.87
Change in WC₹6.64₹10.21-₹9.84₹15.90
Cash flow from Operations-₹7.89₹2.36-₹24.71-₹17.22
Cash flow from Investing-₹4.97-₹7.82-₹12.65-₹22.90
Cash flow from Financing₹12.86₹5.50₹37.34₹39.51
Total Cash Flow₹0.00₹0.05-₹0.01-₹0.61
Cash (Start of the year)₹0.14₹0.09₹0.10₹0.71
Cash (End of the year)₹0.14₹0.14₹0.09₹0.10

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹158.78₹160.73₹158.92₹154.31
Current Assets₹10.26₹17.44₹16.06₹35.49
Total Assets₹169.04₹178.17₹174.98₹189.81
Current Liabilities₹103.53₹61.83₹49.10₹78.06
Net Current Asset-₹93.27-₹44.39-₹33.04-₹42.57
Non-Current Liabilities₹211.75₹235.56₹225.34₹186.83
Equity Capital-₹146.24-₹119.22-₹99.46-₹75.09
Total Equity & Liabilities₹169.04₹178.17₹174.98₹189.81
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
55.99
400
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 400
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
51.86
Neutral
ATR (14)
2.76
Neutral
STOCH(9,6)
33.81
Neutral
STOCH RSI (14)
49.44
Neutral
ADX(9)
26.83
Bearish
UO(9)
40.29
Neutral
ROC(12)
3.36
Bullish
WillR(14)
-66.19
Neutral
Period
Simple value
Exponential vaue
5D
55.23
55.37
10D
55.15
55.27
20D
55.17
55.18
50D
55.35
56.07
100D
58.72
57.52
Volume trend — traded volume by day
7 Sep0L
4 Sep0L
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
KREBS BIOCHEMICALS & INDUSTRIES Share Price
KREBS BIOCHEMICALS & INDUSTRIES
Pharmaceuticals
Add Stock
Add Another

KREBS BIOCHEMICALS & INDUSTRIES Share Price FAQs

KREBS BIOCHEMICALS & INDUSTRIES share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837